Skip to content

Effects of electromyographic biofeedback combined with mirror therapy on balance and walking function in stroke patients

Effects of electromyographic biofeedback combined with mirror therapy on balance and walking function in stroke patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100576
Enrollment
Unknown
Registered
2025-04-11
Start date
2025-01-23
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower extremity motor dysfunction in stroke patients

Interventions

observation group:MT combined with EMGBFT
Control group:EMGBFT

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1?Patients with stroke who meet the diagnostic criteria for major types of cerebrovascular diseases in China 2019, with a first-time and unilateral limb motor and balance dysfunction; 2?Those with stable physical condition and a course of disease = 2, and can maintain sitting position >= 15 min; 6?Sensitive to low-frequency electrical stimulation, which can induce ankle dorslexion; 7?No consciousness, auditory, or visual disorders, good compliance, and cooperative treatment; 8?Those who are aware of this study and have signed informed consent form;

Exclusion criteria

Exclusion criteria: 1?Individuals with cognitive dysfunction, aphasia, and visual and auditory impairments that cannot be corrected; 2?Individuals with severe deformities spasticity in the lower limbs, musculoskeletal disorders, and bilateral lower limb dysfunction; 3?Individuals with a history of mental illness or a history of antipsychotic medications; 4?Individuals with severe heart, lung, liver, or kidney diseases who cannot tolerate 30 minutes of rehabilitation training, and with pacemakers; 5?Individuals who cannot tolerate low-frequency electrical stimulation or are allergic to it; 6?Individuals with local ulcers, ecz, and scars in the area to be stimulated; 7?Individuals who do not cooperate with treatment and those who do not sign the informed consent form;

Design outcomes

Primary

MeasureTime frame
FMA-LE;Tinetti;TUGT;10mMWS;Three-dimensional gait analysis;

Countries

China

Contacts

Public ContactKehui Hu

Suining Central Hospital

1452673713@qq.com+86 18008258682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026